Basics |
Structure Therapeutics Inc.
|
IPO Date: |
February 3, 2023 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.11B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.11 | 3.21%
|
Avg Daily Range (30 D): |
$0.44 | 2.12%
|
Avg Daily Range (90 D): |
$0.61 | 2.88%
|
Institutional Daily Volume |
Avg Daily Volume: |
.67M |
Avg Daily Volume (30 D): |
.71M |
Avg Daily Volume (90 D): |
.81M |
Trade Size |
Avg Trade Size (Sh.): |
86 |
Avg Trade Size (Sh.) (30 D): |
93 |
Avg Trade Size (Sh.) (90 D): |
85 |
Institutional Trades |
Total Inst.Trades: |
1,661 |
Avg Inst. Trade: |
$1.45M |
Avg Inst. Trade (30 D): |
$1.34M |
Avg Inst. Trade (90 D): |
$1.28M |
Avg Inst. Trade Volume: |
.04M |
Avg Inst. Trades (Per Day): |
3 |
Market Closing Trades |
Avg Closing Trade: |
$1.27M |
Avg Closing Trade (30 D): |
$.93M |
Avg Closing Trade (90 D): |
$1.07M |
Avg Closing Volume: |
36.74K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.87
|
$-.27
|
$-.22
|
Diluted EPS
|
$-.87
|
$-.27
|
$-.22
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -143.32M
|
$ -46.83M
|
$ -36.48M
|
Operating Income / Loss
|
$ -182.52M
|
$ -56.31M
|
$ -47.06M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 54.29M
|
$ -17.39M
|
$ -2.62M
|
PE Ratio
|
|
|
|
|
|
|